Clinical Trial

CancerenD24 Screening as an Aid to the Clinician for the Diagnosis of Cancer

Name: CancerenD24 Screening as an Aid to the Clinician for the Diagnosis of Cancer — clinical trial record (NCT06656728)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: CancerenD24

Recruiting

View on ClinicalTrials.gov →

Summary

The purpose of the researchers is to test whether the CancerenD24 index, an algorithm based on the quantitative value of CD24, CD11b, clinical and laboratory characteristics, developed in the laboratory can help in the early detection of a malignant disease in a population of healthy subjects.

Trial Details

NCT Number	NCT06656728
Lead Sponsor	Tel-Aviv Sourasky Medical Center Collaborators: Tel Aviv Medical Center
Conditions	Cancer, Early Detection of Cancer
Enrollment	2,000 participants
Start Date	2024-09-03
Primary Completion	2024-09-04 (estimated)
Study Completion	2027-09 (estimated)
Updated on ClinicalTrials.gov	2024-10-24